FDA's Recent Regulation on the Use of Social Media
Watch the Course Now
Watch the Course Now
About the Course
Social media platforms present significant regulatory and operational challenges for organizations promoting FDA-regulated drug products and medical devices. Public-facing communications must balance benefit and risk information while adapting to character limitations, third-party interactions, and evolving regulatory expectations. Inconsistent handling of promotional content or misinformation can create compliance exposure, particularly when multiple business functions contribute to product messaging and digital communication activities.
The course addresses FDA guidance governing the use of social media within regulated environments and outlines practical considerations for developing compliant policies, procedures, and communication strategies. Attention is given to managing independent third-party content, handling space-restricted platforms, and understanding pending regulatory action from the US Congress. The material is particularly relevant for organizations operating within life sciences, tobacco, and other FDA-regulated sectors where product presentation, electronic systems, and compliance responsibilities frequently intersect. These requirements continue to affect marketing, regulatory, clinical, and technology functions involved in regulated communications.
Key Areas Covered
Quality training, expert insights, and answers that matter. Know your Expert
Ready to Strengthen Your Team? Let’s Build Your Training Plan.
Your team deserves the clarity.
Your organization deserves the confidence.
Upcoming Courses
Your TalkFDA Webinar Experience
1. Confirmation
3. Access course materials
4. Watch The Streaming and Complete your Course


